| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 2.23e-10 | 114 | 168 | 12 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 5.97e-10 | 124 | 168 | 12 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 1.90e-09 | 137 | 168 | 12 | GO:0019783 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 6.49e-08 | 26 | 168 | 6 | GO:0005248 | |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 8.46e-08 | 192 | 168 | 12 | GO:0008234 |
| GeneOntologyMolecularFunction | sodium ion binding | 4.53e-06 | 14 | 168 | 4 | GO:0031402 | |
| GeneOntologyMolecularFunction | sodium channel activity | 4.79e-06 | 52 | 168 | 6 | GO:0005272 | |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 2.95e-05 | 43 | 168 | 5 | GO:0030280 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 6.25e-05 | 26 | 168 | 4 | GO:0031420 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNB3 OTOP3 KCNH4 ITPR1 SCN1A SCN2A SCN5A PKD1 SCN8A SCN9A CACNA1H | 1.61e-04 | 343 | 168 | 11 | GO:0005261 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | ANO2 CACNB3 OTOP3 KCNH4 ITPR1 SCN1A SCN2A SCN5A PKD1 SCN8A SCN9A CACNA1H | 5.25e-04 | 459 | 168 | 12 | GO:0005216 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L21 RHBDF1 USP17L12 USP17L20 USP17L11 AZU1 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 1.30e-03 | 654 | 168 | 14 | GO:0008233 |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 3.71e-10 | 125 | 165 | 12 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 1.91e-09 | 144 | 165 | 12 | GO:0070646 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 1.27e-08 | 36 | 165 | 7 | GO:0086010 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | 5.51e-08 | 44 | 165 | 7 | GO:0048026 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | SRRM1 RBMXL3 RBMY1A1 RBMY1C RBMY1D RBMY1B RBMY1E SRSF12 RBMY1F SRSF9 | 8.86e-08 | 129 | 165 | 10 | GO:0048024 |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | 1.19e-07 | 49 | 165 | 7 | GO:0050685 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | SRRM1 RBMXL3 RBMY1A1 RBMY1C RBMY1D RBMY1B RBMY1E SRSF12 RBMY1F SRSF9 | 5.90e-07 | 158 | 165 | 10 | GO:0050684 |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 7.01e-07 | 63 | 165 | 7 | GO:0033120 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 7.01e-07 | 63 | 165 | 7 | GO:0019228 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | SRRM1 RBMXL3 RBMY1A1 RBMY1C RBMY1D RBMY1B RBMY1E SRSF12 RBMY1F SRSF9 | 6.75e-06 | 207 | 165 | 10 | GO:0043484 |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 3.31e-05 | 112 | 165 | 7 | GO:0019226 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 5.43e-05 | 121 | 165 | 7 | GO:0051899 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | GTPBP4 USP17L21 DCAF6 TRAF6 USP17L12 USP17L20 USP17L11 RC3H1 USP17L24 USP17L5 USP17L19 HUWE1 USP17L18 RASSF5 USP17L17 SH3RF2 DDRGK1 USP17L22 USP17L15 USP17L13 FBXW7 | 5.76e-05 | 1009 | 165 | 21 | GO:0070647 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 7.08e-05 | 87 | 165 | 6 | GO:0086001 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 1.03e-04 | 93 | 165 | 6 | GO:0086003 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.38e-04 | 62 | 165 | 5 | GO:0086002 | |
| GeneOntologyBiologicalProcess | post-translational protein modification | GTPBP4 USP17L21 DCAF6 TRAF6 USP17L12 USP17L20 USP17L11 RC3H1 USP17L24 USP17L5 USP17L19 HUWE1 USP17L18 RASSF5 USP17L17 SH3RF2 DDRGK1 USP17L22 USP17L15 USP17L13 FBXW7 | 1.38e-04 | 1074 | 165 | 21 | GO:0043687 |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 1.44e-04 | 189 | 165 | 8 | GO:0030216 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 1.45e-04 | 99 | 165 | 6 | GO:0045104 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | SRRM1 RBMXL3 RBMY1A1 RBMY1C RBMY1D RBMY1B RBMY1E SRSF12 RBMY1F SRRM2 SRSF9 | 1.50e-04 | 358 | 165 | 11 | GO:0000398 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | SRRM1 RBMXL3 RBMY1A1 RBMY1C RBMY1D RBMY1B RBMY1E SRSF12 RBMY1F SRRM2 SRSF9 | 1.50e-04 | 358 | 165 | 11 | GO:0000377 |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 1.53e-04 | 100 | 165 | 6 | GO:0045103 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | SRRM1 RBMXL3 RBMY1A1 RBMY1C RBMY1D RBMY1B RBMY1E SRSF12 RBMY1F SRRM2 SRSF9 | 1.66e-04 | 362 | 165 | 11 | GO:0000375 |
| GeneOntologyBiologicalProcess | action potential | 2.20e-04 | 201 | 165 | 8 | GO:0001508 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 2.35e-04 | 153 | 165 | 7 | GO:0030048 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | SRRM1 RBMXL3 RC3H1 RBMY1A1 RBMY1C RBMY1D RBMY1B RBMY1E ZFP36 SRSF12 RBMY1F SRSF9 | 2.43e-04 | 443 | 165 | 12 | GO:1903311 |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | RBMXL3 RC3H1 RBMY1A1 RBMY1C RBMY1D RBMY1B RBMY1E ZFP36 RBMY1F | 2.47e-04 | 259 | 165 | 9 | GO:1903313 |
| GeneOntologyBiologicalProcess | cerebellar cortex development | 2.62e-04 | 71 | 165 | 5 | GO:0021695 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 2.77e-04 | 208 | 165 | 8 | GO:0035725 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 3.39e-04 | 75 | 165 | 5 | GO:0045109 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception of pain | 3.82e-04 | 43 | 165 | 4 | GO:0062149 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 3.83e-04 | 275 | 165 | 9 | GO:0006814 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 4.00e-04 | 167 | 165 | 7 | GO:0060048 | |
| GeneOntologyBiologicalProcess | neuromuscular process | 4.69e-04 | 225 | 165 | 8 | GO:0050905 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron differentiation | 4.70e-04 | 123 | 165 | 6 | GO:0045666 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 4.83e-04 | 284 | 165 | 9 | GO:0009913 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 5.57e-04 | 127 | 165 | 6 | GO:0070252 | |
| GeneOntologyBiologicalProcess | cerebellar cortex morphogenesis | 5.84e-04 | 48 | 165 | 4 | GO:0021696 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor localization to postsynaptic specialization membrane | 6.32e-04 | 49 | 165 | 4 | GO:0099645 | |
| GeneOntologyBiologicalProcess | protein localization to postsynaptic specialization membrane | 6.32e-04 | 49 | 165 | 4 | GO:0099633 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 2.64e-09 | 17 | 166 | 6 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 9.35e-08 | 29 | 166 | 6 | GO:0034706 | |
| GeneOntologyCellularComponent | axon | CNTNAP3B NRG1 MYH10 ANK3 KIF1A GIT1 MYO9A LRFN3 CNTNAP3 SYBU ARHGAP4 ADRA2C SCN1A SCN2A SCN5A SCN8A SCN9A SMO ULK1 TMEM151A ROBO3 DAGLA INPP5J | 6.33e-07 | 891 | 166 | 23 | GO:0030424 |
| GeneOntologyCellularComponent | node of Ranvier | 1.68e-05 | 20 | 166 | 4 | GO:0033268 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 3.67e-05 | 78 | 166 | 6 | GO:0048787 | |
| GeneOntologyCellularComponent | spliceosomal complex | SRRM1 RBMXL3 RBMY1A1 RBMY1C RBMY1D RBMY1B RBMY1E RBMY1F SRRM2 | 5.72e-05 | 215 | 166 | 9 | GO:0005681 |
| GeneOntologyCellularComponent | supramolecular fiber | KRT6A KRT6B SHROOM3 MYH10 ANK3 KIF1A MYO9A SEPTIN9 TOGARAM1 SYBU TRIP10 KIFC2 KRT73 FAM83H RASSF5 ARHGAP4 KRT6C INF2 SCN1A SCN5A SCN8A ARHGEF2 BFSP2 | 6.03e-05 | 1179 | 166 | 23 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT6A KRT6B SHROOM3 MYH10 ANK3 KIF1A MYO9A SEPTIN9 TOGARAM1 SYBU TRIP10 KIFC2 KRT73 FAM83H RASSF5 ARHGAP4 KRT6C INF2 SCN1A SCN5A SCN8A ARHGEF2 BFSP2 | 6.68e-05 | 1187 | 166 | 23 | GO:0099081 |
| GeneOntologyCellularComponent | axon initial segment | 7.80e-05 | 29 | 166 | 4 | GO:0043194 | |
| GeneOntologyCellularComponent | cation channel complex | 1.13e-04 | 235 | 166 | 9 | GO:0034703 | |
| GeneOntologyCellularComponent | presynaptic active zone | 1.36e-04 | 141 | 166 | 7 | GO:0048786 | |
| GeneOntologyCellularComponent | synaptic membrane | NRG1 ANO2 ANK3 LRFN3 IQSEC2 ITPR1 ADRA2C NRXN3 P2RY4 SCN1A SCN2A SCN8A CACNA1H DAGLA | 2.39e-04 | 583 | 166 | 14 | GO:0097060 |
| GeneOntologyCellularComponent | glutamatergic synapse | NRG1 ANO2 MYH10 TRAF6 PSD2 GIT1 MYO9A LRFN3 IQSEC2 ADRA2C NRXN3 P2RY4 CASKIN1 SCN2A SCN8A CACNA1H ARHGEF2 | 2.82e-04 | 817 | 166 | 17 | GO:0098978 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT6A KRT6B SHROOM3 KIF1A MYO9A SEPTIN9 TOGARAM1 SYBU TRIP10 KIFC2 KRT73 FAM83H RASSF5 ARHGAP4 KRT6C INF2 ARHGEF2 BFSP2 | 2.96e-04 | 899 | 166 | 18 | GO:0099513 |
| GeneOntologyCellularComponent | presynaptic membrane | 3.83e-04 | 277 | 166 | 9 | GO:0042734 | |
| GeneOntologyCellularComponent | T-tubule | 4.17e-04 | 79 | 166 | 5 | GO:0030315 | |
| GeneOntologyCellularComponent | main axon | 7.21e-04 | 89 | 166 | 5 | GO:0044304 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | ANO2 CACNB3 KCNH4 SCN1A SCN2A SCN5A PKD1 SCN8A SCN9A CACNA1H | 9.09e-04 | 378 | 166 | 10 | GO:0034702 |
| GeneOntologyCellularComponent | postsynaptic density | NRG1 ANK3 GIT1 LRFN3 IQSEC2 ITPR1 PRR12 ADRA2C SCN8A ARHGEF2 DAGLA | 9.86e-04 | 451 | 166 | 11 | GO:0014069 |
| GeneOntologyCellularComponent | keratin filament | 1.06e-03 | 97 | 166 | 5 | GO:0045095 | |
| GeneOntologyCellularComponent | asymmetric synapse | NRG1 ANK3 GIT1 LRFN3 IQSEC2 ITPR1 PRR12 ADRA2C SCN8A ARHGEF2 DAGLA | 1.54e-03 | 477 | 166 | 11 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.61e-03 | 157 | 166 | 6 | GO:0098839 | |
| GeneOntologyCellularComponent | intercalated disc | 2.10e-03 | 68 | 166 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | postsynaptic specialization | NRG1 ANK3 GIT1 LRFN3 IQSEC2 ITPR1 PRR12 ADRA2C SCN8A ARHGEF2 DAGLA | 2.33e-03 | 503 | 166 | 11 | GO:0099572 |
| GeneOntologyCellularComponent | postsynapse | NRG1 MYH10 PSD2 ANK3 KIF1A GIT1 MYO9A LRFN3 IQSEC2 ITPR1 PRR12 ADRA2C CASKIN1 SCN8A CACNA1H ARHGEF2 DAGLA | 3.09e-03 | 1018 | 166 | 17 | GO:0098794 |
| GeneOntologyCellularComponent | neuron to neuron synapse | NRG1 ANK3 GIT1 LRFN3 IQSEC2 ITPR1 PRR12 ADRA2C SCN8A ARHGEF2 DAGLA | 3.14e-03 | 523 | 166 | 11 | GO:0098984 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L21 RHBDF1 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 TXNDC11 ITPR1 USP17L18 USP17L17 SEC16A MMGT1 DDRGK1 ULK1 TMEM151A USP17L22 USP17L15 SOAT2 USP17L13 | 3.26e-03 | 1293 | 166 | 20 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L21 RHBDF1 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 TXNDC11 ITPR1 USP17L18 USP17L17 SEC16A MMGT1 DDRGK1 ULK1 TMEM151A USP17L22 USP17L15 SOAT2 USP17L13 | 3.44e-03 | 1299 | 166 | 20 | GO:0098827 |
| HumanPheno | Focal hemiclonic seizure | 6.57e-06 | 25 | 57 | 5 | HP:0006813 | |
| HumanPheno | Complex febrile seizure | 2.32e-05 | 16 | 57 | 4 | HP:0011172 | |
| HumanPheno | Paronychia | 2.32e-05 | 16 | 57 | 4 | HP:0001818 | |
| HumanPheno | Photosensitive myoclonic seizure | 7.15e-05 | 8 | 57 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 7.15e-05 | 8 | 57 | 3 | HP:0200048 | |
| HumanPheno | Abnormality of the periungual region | 8.87e-05 | 22 | 57 | 4 | HP:0100803 | |
| HumanPheno | Focal clonic seizure | 9.10e-05 | 42 | 57 | 5 | HP:0002266 | |
| HumanPheno | Deep anterior chamber | 1.23e-04 | 2 | 57 | 2 | HP:0007765 | |
| MousePheno | postnatal lethality | KRT6A KRT6B TCF3 MYH10 TRAF6 RHBDF1 ANK3 KIF1A GIT1 MYO9A SPEG NPAS3 NAGS FAM83H ITPR1 NRXN3 SH3RF2 GLI2 SCN1A SCN2A SCN5A PKD1 SCN8A SCN9A DNMT3B | 7.92e-06 | 1084 | 124 | 25 | MP:0002082 |
| MousePheno | postnatal lethality, complete penetrance | KRT6A KRT6B MYH10 TRAF6 RHBDF1 ANK3 KIF1A SPEG NAGS GLI2 SCN1A SCN2A PKD1 SCN8A DNMT3B | 9.18e-06 | 445 | 124 | 15 | MP:0011085 |
| MousePheno | abnormal fetal atrioventricular canal septation | 5.50e-05 | 9 | 124 | 3 | MP:0010599 | |
| MousePheno | failure of atrioventricular cushion closure | 5.50e-05 | 9 | 124 | 3 | MP:0000299 | |
| Domain | HABP4_PAI-RBP1 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 4.70e-20 | 16 | 158 | 11 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 4.70e-20 | 16 | 158 | 11 | IPR006861 |
| Domain | USP_CS | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 8.04e-12 | 66 | 158 | 11 | IPR018200 |
| Domain | USP_1 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 1.57e-11 | 70 | 158 | 11 | PS00972 |
| Domain | UCH | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 1.85e-11 | 71 | 158 | 11 | PF00443 |
| Domain | USP_2 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 1.85e-11 | 71 | 158 | 11 | PS00973 |
| Domain | USP_3 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 2.17e-11 | 72 | 158 | 11 | PS50235 |
| Domain | USP_dom | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 2.17e-11 | 72 | 158 | 11 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 2.17e-11 | 72 | 158 | 11 | IPR001394 |
| Domain | Na_trans_cytopl | 2.42e-10 | 6 | 158 | 5 | PF11933 | |
| Domain | Na_trans_cytopl | 2.42e-10 | 6 | 158 | 5 | IPR024583 | |
| Domain | RBM1CTR | 2.23e-09 | 8 | 158 | 5 | PF08081 | |
| Domain | RBM1CTR | 2.23e-09 | 8 | 158 | 5 | IPR012604 | |
| Domain | IQ_motif_EF-hand-BS | DCAF6 MYH10 MYO9A IQSEC2 MYO15B SCN1A SCN2A SCN5A SCN8A SCN9A | 4.51e-09 | 90 | 158 | 10 | IPR000048 |
| Domain | IQ | DCAF6 MYH10 MYO9A IQSEC2 MYO15B SCN1A SCN2A SCN5A SCN8A SCN9A | 6.24e-09 | 93 | 158 | 10 | PS50096 |
| Domain | Na_channel_asu | 9.90e-09 | 10 | 158 | 5 | IPR001696 | |
| Domain | Na_trans_assoc | 9.90e-09 | 10 | 158 | 5 | IPR010526 | |
| Domain | Na_trans_assoc | 9.90e-09 | 10 | 158 | 5 | PF06512 | |
| Domain | IQ | 4.19e-07 | 81 | 158 | 8 | SM00015 | |
| Domain | Ion_trans_dom | 5.66e-06 | 114 | 158 | 8 | IPR005821 | |
| Domain | Ion_trans | 5.66e-06 | 114 | 158 | 8 | PF00520 | |
| Domain | Channel_four-helix_dom | 8.47e-06 | 57 | 158 | 6 | IPR027359 | |
| Domain | - | 8.47e-06 | 57 | 158 | 6 | 1.20.120.350 | |
| Domain | IQ | 3.03e-05 | 71 | 158 | 6 | PF00612 | |
| Domain | Keratin_2_head | 4.59e-05 | 24 | 158 | 4 | IPR032444 | |
| Domain | Keratin_2_head | 4.59e-05 | 24 | 158 | 4 | PF16208 | |
| Domain | Keratin_II | 6.37e-05 | 26 | 158 | 4 | IPR003054 | |
| Domain | RRM_1 | RBMXL3 PPRC1 RBMY1A1 RBMY1D RBMY1B RBMY1E SRSF12 RBMY1F SRSF9 | 7.11e-05 | 208 | 158 | 9 | PF00076 |
| Domain | SM_dom_ATX | 7.11e-05 | 2 | 158 | 2 | IPR025852 | |
| Domain | LsmAD | 7.11e-05 | 2 | 158 | 2 | PF06741 | |
| Domain | LsmAD_domain | 7.11e-05 | 2 | 158 | 2 | IPR009604 | |
| Domain | LsmAD | 7.11e-05 | 2 | 158 | 2 | SM01272 | |
| Domain | SM-ATX | 7.11e-05 | 2 | 158 | 2 | PF14438 | |
| Domain | RRM | RBMXL3 PPRC1 RBMY1A1 RBMY1D RBMY1B RBMY1E SRSF12 RBMY1F SRSF9 | 9.83e-05 | 217 | 158 | 9 | SM00360 |
| Domain | RRM_dom | RBMXL3 PPRC1 RBMY1A1 RBMY1D RBMY1B RBMY1E SRSF12 RBMY1F SRSF9 | 1.38e-04 | 227 | 158 | 9 | IPR000504 |
| Domain | RRM | RBMXL3 PPRC1 RBMY1A1 RBMY1D RBMY1B RBMY1E SRSF12 RBMY1F SRSF9 | 1.53e-04 | 230 | 158 | 9 | PS50102 |
| Domain | Filament | 3.38e-04 | 71 | 158 | 5 | SM01391 | |
| Domain | Nucleotide-bd_a/b_plait | RBMXL3 PPRC1 RBMY1A1 RBMY1D RBMY1B RBMY1E SRSF12 RBMY1F SRSF9 | 3.58e-04 | 258 | 158 | 9 | IPR012677 |
| Domain | IF | 3.60e-04 | 72 | 158 | 5 | PS00226 | |
| Domain | Filament | 3.84e-04 | 73 | 158 | 5 | PF00038 | |
| Domain | IF | 4.63e-04 | 76 | 158 | 5 | IPR001664 | |
| Domain | SH3 | 5.13e-04 | 216 | 158 | 8 | SM00326 | |
| Domain | SH3 | 5.13e-04 | 216 | 158 | 8 | PS50002 | |
| Domain | SH3_domain | 5.79e-04 | 220 | 158 | 8 | IPR001452 | |
| Domain | - | 1.13e-03 | 244 | 158 | 8 | 3.30.70.330 | |
| Domain | Intermediate_filament_CS | 1.99e-03 | 63 | 158 | 4 | IPR018039 | |
| Domain | RA | 2.24e-03 | 31 | 158 | 3 | SM00314 | |
| Domain | FHA_DOMAIN | 2.24e-03 | 31 | 158 | 3 | PS50006 | |
| Domain | FHA | 2.24e-03 | 31 | 158 | 3 | PF00498 | |
| Domain | PAS | 2.46e-03 | 32 | 158 | 3 | SM00091 | |
| Domain | Ataxin-2_C | 2.46e-03 | 9 | 158 | 2 | IPR009818 | |
| Domain | PAM2 | 2.46e-03 | 9 | 158 | 2 | PF07145 | |
| Domain | RhoGEF | 2.64e-03 | 68 | 158 | 4 | SM00325 | |
| Domain | RhoGEF | 2.93e-03 | 70 | 158 | 4 | PF00621 | |
| Domain | DH_2 | 2.93e-03 | 70 | 158 | 4 | PS50010 | |
| Domain | PAS | 2.93e-03 | 34 | 158 | 3 | PS50112 | |
| Domain | PAS | 2.93e-03 | 34 | 158 | 3 | IPR000014 | |
| Domain | PAS_9 | 3.06e-03 | 10 | 158 | 2 | PF13426 | |
| Domain | - | 3.09e-03 | 71 | 158 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 3.09e-03 | 71 | 158 | 4 | IPR000219 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 7.72e-14 | 45 | 119 | 11 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 TRAF6 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 4.38e-08 | 221 | 119 | 13 | M27578 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 TRAF6 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 7.26e-08 | 191 | 119 | 12 | MM15289 |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.98e-07 | 31 | 119 | 6 | M877 | |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 TRAF6 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 1.42e-06 | 299 | 119 | 13 | M27574 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 TRAF6 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 2.15e-06 | 262 | 119 | 12 | MM15286 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L21 NRG1 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 RGL2 USP17L15 USP17L13 | 2.80e-06 | 318 | 119 | 13 | MM15278 |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 6.61e-06 | 32 | 119 | 5 | M27455 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 8.67e-21 | 21 | 169 | 11 | 8622927 |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 8.67e-21 | 21 | 169 | 11 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 8.67e-21 | 21 | 169 | 11 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 8.67e-21 | 21 | 169 | 11 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 8.67e-21 | 21 | 169 | 11 | 12447969 |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 8.67e-21 | 21 | 169 | 11 | 18980247 | |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 1.73e-20 | 22 | 169 | 11 | 9154835 | |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 3.78e-20 | 33 | 169 | 12 | 20228807 | |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 5.82e-20 | 34 | 169 | 12 | 20403174 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 5.82e-20 | 34 | 169 | 12 | 14699124 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 5.82e-20 | 34 | 169 | 12 | 15780755 |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 5.82e-20 | 34 | 169 | 12 | 19188362 |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 5.82e-20 | 34 | 169 | 12 | 11941478 | |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 5.82e-20 | 34 | 169 | 12 | 17109758 | |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 5.82e-20 | 34 | 169 | 12 | 20388806 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 5.82e-20 | 34 | 169 | 12 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 5.82e-20 | 34 | 169 | 12 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 5.82e-20 | 34 | 169 | 12 | 20368735 |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 5.82e-20 | 34 | 169 | 12 | 10936051 | |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 5.82e-20 | 34 | 169 | 12 | 21448158 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 6.06e-20 | 24 | 169 | 11 | 8995226 |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 8.83e-20 | 35 | 169 | 12 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 8.83e-20 | 35 | 169 | 12 | 21239494 |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 1.08e-19 | 25 | 169 | 11 | 21115691 | |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 1.32e-19 | 36 | 169 | 12 | 20147298 | |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 1.86e-19 | 26 | 169 | 11 | 35816173 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 1.94e-19 | 37 | 169 | 12 | 20228808 |
| Pubmed | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 8.22e-19 | 29 | 169 | 11 | 32527007 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ARHGEF19 SHROOM3 RHBDF1 OFD1 PPRC1 POLE SPEG FBXL14 HUWE1 MLLT10 KIFC2 FAM83H PRR12 PHLDB1 ZNF276 KANSL1 ZNF296 INF2 NEK8 CASKIN1 ZNF516 SCN5A PKD1 SCN8A SEC16A CENPV MLLT6 CACNA1H ULK1 ARHGEF2 RGL2 MVB12B | 3.77e-16 | 1105 | 169 | 32 | 35748872 |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 8.13e-16 | 50 | 169 | 11 | 31806660 |
| Pubmed | 8.39e-14 | 7 | 169 | 6 | 8269511 | ||
| Pubmed | 1.09e-11 | 12 | 169 | 6 | 9598316 | ||
| Pubmed | 1.53e-11 | 6 | 169 | 5 | 15184870 | ||
| Pubmed | Degeneracy in human multicopy RBM (YRRM), a candidate spermatogenesis gene. | 5.32e-11 | 7 | 169 | 5 | 8875892 | |
| Pubmed | 3.17e-10 | 9 | 169 | 5 | 16382098 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 1.97e-09 | 12 | 169 | 5 | 30175250 | |
| Pubmed | An RBM homologue maps to the mouse Y chromosome and is expressed in germ cells. | 2.68e-09 | 5 | 169 | 4 | 8817321 | |
| Pubmed | 2.68e-09 | 5 | 169 | 4 | 20016065 | ||
| Pubmed | The role of human and mouse Y chromosome genes in male infertility. | 2.68e-09 | 5 | 169 | 4 | 11097427 | |
| Pubmed | Rapid evolution of mouse Y centromere repeat DNA belies recent sequence stability. | 2.68e-09 | 5 | 169 | 4 | 19737860 | |
| Pubmed | 3.18e-09 | 13 | 169 | 5 | 10749975 | ||
| Pubmed | 3.18e-09 | 13 | 169 | 5 | 15123669 | ||
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | USP17L21 USP17L12 USP17L20 USP17L11 RBMY1D USP17L19 USP17L18 USP17L17 DDRGK1 | 7.46e-09 | 119 | 169 | 9 | 28625976 |
| Pubmed | Identification of target messenger RNA substrates for mouse RBMY. | 8.01e-09 | 6 | 169 | 4 | 18492746 | |
| Pubmed | Meiotic sex chromosome inactivation in male mice with targeted disruptions of Xist. | 8.01e-09 | 6 | 169 | 4 | 12356914 | |
| Pubmed | 8.01e-09 | 6 | 169 | 4 | 9499427 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 8.01e-09 | 6 | 169 | 4 | 23652591 | |
| Pubmed | 8.01e-09 | 6 | 169 | 4 | 18239052 | ||
| Pubmed | 8.01e-09 | 6 | 169 | 4 | 15051956 | ||
| Pubmed | The roles of RNA-binding proteins in spermatogenesis and male infertility. | 1.86e-08 | 7 | 169 | 4 | 10377282 | |
| Pubmed | 1.86e-08 | 7 | 169 | 4 | 17001072 | ||
| Pubmed | 3.71e-08 | 8 | 169 | 4 | 7479793 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ATXN2L SRRM1 SHROOM3 OFD1 GIT1 MYO9A IQSEC2 ANKRD26 FAM83H PHLDB1 SEC16A MAP3K9 FAM53B PROSER2 ARHGEF2 SRRM2 RGL2 WNK4 CFAP97 | 4.69e-08 | 861 | 169 | 19 | 36931259 |
| Pubmed | 6.65e-08 | 9 | 169 | 4 | 15746173 | ||
| Pubmed | 1.10e-07 | 10 | 169 | 4 | 10601091 | ||
| Pubmed | 1.10e-07 | 10 | 169 | 4 | 9384609 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 29357356 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 7543104 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 32845893 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 28518218 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 17928448 | ||
| Pubmed | USP17L21 USP17L12 OFD1 NHSL2 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 EZHIP SAMD9L USP17L17 SCN2A USP17L22 USP17L15 USP17L13 | 2.18e-07 | 674 | 169 | 16 | 37196079 | |
| Pubmed | The role of Dby mRNA in early development of male mouse zygotes. | 2.58e-07 | 12 | 169 | 4 | 20543856 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | HMBOX1 GTPBP4 FLG SRRM1 KRT6A KRT6B MYH10 MCM7 KRT73 ZNF296 KRT6C MDC1 CENPV SRRM2 SRSF9 | 3.07e-07 | 605 | 169 | 15 | 28977666 |
| Pubmed | GASZ promotes germ cell derivation from embryonic stem cells. | 3.72e-07 | 13 | 169 | 4 | 23816659 | |
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 17537961 | ||
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 35031483 | ||
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 29578003 | ||
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 30389720 | ||
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 21156207 | ||
| Pubmed | Absence of mDazl produces a final block on germ cell development at meiosis. | 5.19e-07 | 14 | 169 | 4 | 14611631 | |
| Pubmed | Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome. | 7.04e-07 | 15 | 169 | 4 | 14762062 | |
| Pubmed | MYH10 PPRC1 SEPTIN9 SPEG PHLDB1 KANSL1 SEC16A CACNA1H YY1AP1 ULK1 SRRM2 TMEM181 | 8.19e-07 | 407 | 169 | 12 | 12693553 | |
| Pubmed | 1.12e-06 | 5 | 169 | 3 | 8812438 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 1.12e-06 | 5 | 169 | 3 | 22875929 | |
| Pubmed | 1.12e-06 | 5 | 169 | 3 | 17724025 | ||
| Pubmed | 1.12e-06 | 5 | 169 | 3 | 20301457 | ||
| Pubmed | Loss of maternal Trim28 causes male-predominant early embryonic lethality. | 1.22e-06 | 17 | 169 | 4 | 28115466 | |
| Pubmed | Sex differences in sex chromosome gene expression in mouse brain. | 1.56e-06 | 18 | 169 | 4 | 12023983 | |
| Pubmed | HMBOX1 GTPBP4 FLG TCF3 MYH10 OFD1 RC3H1 MLLT10 ARID3B PRR12 KANSL1 ATXN2 GLI2 MDC1 ZNF516 SEC16A MLLT6 YY1AP1 SRRM2 SLX4 FBXW7 NPAT | 1.85e-06 | 1429 | 169 | 22 | 35140242 | |
| Pubmed | Are voltage-dependent ion channels involved in the endothelial cell control of vasomotor tone? | 2.23e-06 | 6 | 169 | 3 | 17513486 | |
| Pubmed | Downregulating hedgehog signaling reduces renal cystogenic potential of mouse models. | 2.23e-06 | 6 | 169 | 3 | 24700869 | |
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 3.89e-06 | 7 | 169 | 3 | 25818041 | |
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 15272007 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | ATXN2L KIF1A GIT1 SEPTIN9 ITPR1 PRR12 KANSL1 ATXN2 CASKIN1 SCN8A SCN9A INPP5J | 4.03e-06 | 475 | 169 | 12 | 31040226 |
| Pubmed | Hedgehog signalling controls sinoatrial node development and atrioventricular cushion formation. | 5.30e-06 | 24 | 169 | 4 | 34062094 | |
| Pubmed | UPF2 is a critical regulator of liver development, function and regeneration. | 5.30e-06 | 24 | 169 | 4 | 20657840 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | GTPBP4 SRRM1 NRG1 SHROOM3 PPM1D SEPTIN9 POLE SNUPN HUWE1 MYO15B KANSL1 ARHGEF2 SRRM2 | 6.02e-06 | 582 | 169 | 13 | 20467437 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATXN2L SRRM1 GIT1 SEPTIN9 HUWE1 CLASRP KANSL1 MDC1 ZNF516 SEC16A YY1AP1 PROSER2 ARHGEF2 SRRM2 SRSF9 | 6.33e-06 | 774 | 169 | 15 | 15302935 |
| Pubmed | 7.40e-06 | 26 | 169 | 4 | 35920200 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SHROOM3 ANK3 MLLT10 ATXN2 GLI2 SCN1A MDC1 MLLT6 TMEM151A WNK4 DNMT3B | 9.14e-06 | 430 | 169 | 11 | 35044719 |
| Pubmed | Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. | 9.27e-06 | 9 | 169 | 3 | 17884088 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | GTPBP4 KRT6B MYH10 MYO9A SEPTIN9 POLE MCM7 HUWE1 FAM83H TGM1 SLX9 PHLDB1 KANSL1 INF2 MDC1 SEC16A ARHGEF2 SRRM2 SRSF9 STOML2 | 1.02e-05 | 1353 | 169 | 20 | 29467282 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | GTPBP4 ATXN2L GIT1 MCM7 HUWE1 TRIP10 ITPR1 MDC1 SEC16A ARHGEF2 SLX4 | 1.13e-05 | 440 | 169 | 11 | 34244565 |
| Pubmed | 1.16e-05 | 29 | 169 | 4 | 36800290 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | GTPBP4 SRRM1 ANK3 TOGARAM1 SFMBT2 CLASRP PHLDB1 SAMD9L MDC1 SRRM2 | 1.19e-05 | 361 | 169 | 10 | 26167880 |
| Pubmed | 1.32e-05 | 10 | 169 | 3 | 10332027 | ||
| Pubmed | 1.66e-05 | 298 | 169 | 9 | 30737378 | ||
| Pubmed | 1.81e-05 | 11 | 169 | 3 | 35593401 | ||
| Pubmed | The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. | 1.97e-05 | 33 | 169 | 4 | 22357600 | |
| Interaction | TOP3B interactions | ARHGEF19 SHROOM3 MYH10 RHBDF1 OFD1 PPRC1 POLE SPEG FBXL14 HUWE1 MLLT10 KIFC2 ZFP36 FAM83H PRR12 PHLDB1 ZNF276 KANSL1 ZNF296 ATXN2 INF2 NEK8 CASKIN1 MDC1 ZNF516 SCN5A PKD1 SCN8A SEC16A DDRGK1 CENPV MLLT6 CACNA1H ULK1 ARHGEF2 RGL2 SRSF9 MVB12B | 1.49e-10 | 1470 | 165 | 38 | int:TOP3B |
| Interaction | YWHAG interactions | GTPBP4 ATXN2L SRRM1 SHROOM3 MYH10 GIT1 MYO9A NHSL2 SPEG RC3H1 IQSEC2 ANKRD26 HUWE1 ZFP36 FAM83H SRSF12 PHLDB1 SEC16A MAP3K9 FAM53B ULK1 PROSER2 ARHGEF2 SRRM2 RGL2 CFAP97 FBXW7 | 3.33e-06 | 1248 | 165 | 27 | int:YWHAG |
| Interaction | SCN11A interactions | 5.51e-06 | 15 | 165 | 4 | int:SCN11A | |
| Interaction | YWHAH interactions | ATXN2L SRRM1 SHROOM3 OFD1 GIT1 MYO9A NHSL2 SPEG IQSEC2 ANKRD26 HUWE1 ZFP36 FAM83H SRSF12 SLX9 PHLDB1 SEC16A MAP3K9 FAM53B PROSER2 ARHGEF2 SRRM2 RGL2 CFAP97 | 1.12e-05 | 1102 | 165 | 24 | int:YWHAH |
| Interaction | SCN4B interactions | 2.93e-05 | 8 | 165 | 3 | int:SCN4B | |
| Interaction | NEUROG3 interactions | 3.19e-05 | 149 | 165 | 8 | int:NEUROG3 | |
| Cytoband | 4p16.1 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 1.72e-16 | 79 | 169 | 12 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 ADRA2C USP17L17 USP17L22 USP17L15 USP17L13 | 2.62e-12 | 222 | 169 | 13 | chr4p16 |
| Cytoband | Yq11.223 | 2.55e-05 | 93 | 169 | 5 | Yq11.223 | |
| Cytoband | 12q13.13 | 1.13e-04 | 67 | 169 | 4 | 12q13.13 | |
| Cytoband | 12q24.3 | 2.00e-04 | 6 | 169 | 2 | 12q24.3 | |
| Cytoband | 16p13.3 | 3.05e-04 | 244 | 169 | 6 | 16p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 1.03e-03 | 423 | 169 | 7 | chr12q13 | |
| Cytoband | Xp11.22 | 1.06e-03 | 54 | 169 | 3 | Xp11.22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 1.07e-03 | 426 | 169 | 7 | chr16p13 | |
| Cytoband | 2q24.3 | 1.56e-03 | 16 | 169 | 2 | 2q24.3 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 6.73e-10 | 9 | 103 | 5 | 1203 | |
| GeneFamily | RNA binding motif containing | RBMXL3 PPRC1 RBMY1A1 RBMY1C RBMY1D RBMY1B RBMY1E SRSF12 RBMY1F SRSF9 | 3.79e-07 | 213 | 103 | 10 | 725 |
| GeneFamily | Keratins, type II | 1.58e-05 | 27 | 103 | 4 | 609 | |
| GeneFamily | RNA binding motif containing|Serine and arginine rich splicing factors | 2.04e-03 | 12 | 103 | 2 | 737 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 TXNDC11 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 7.12e-12 | 112 | 166 | 12 | MM1095 |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 7.64e-12 | 86 | 166 | 11 | MM1312 |
| Coexpression | GERY_CEBP_TARGETS | USP17L21 USP17L12 ANK3 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 4.78e-10 | 160 | 166 | 12 | MM1155 |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP | CACNB3 RHBDF1 POLE TMEM80 KIFC2 SFMBT2 ZNF296 ATXN2 SEC16A ULK1 SRRM2 RGL2 INPP5J | 1.15e-06 | 385 | 166 | 13 | M2840 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 FAM83H USP17L18 RASSF5 ZNF296 USP17L17 ULK1 USP17L22 USP17L15 STOML2 USP17L13 | 3.88e-06 | 647 | 166 | 16 | MM981 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | USP17L21 MYH10 USP17L12 OFD1 POLM USP17L20 SETD6 USP17L11 SEPTIN9 C15orf40 USP17L5 USP17L19 MLLT10 USP17L18 USP17L17 PKD1 CENPV ROBO3 USP17L22 USP17L15 STOML2 USP17L13 | 7.35e-06 | 1198 | 166 | 22 | MM1062 |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 5.50e-05 | 33 | 166 | 4 | MM701 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.88e-06 | 181 | 158 | 7 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.17e-06 | 183 | 158 | 7 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.48e-06 | 185 | 158 | 7 | f3fbc3096f85397a959cee17c3c4fcf2d511f3d5 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.98e-06 | 188 | 158 | 7 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | Globus_pallidus|World / BrainAtlas - Mouse McCarroll V32 | 5.93e-06 | 126 | 158 | 6 | 44b63f945d5bedf1a2ca1810e7e100276ea9dd89 | |
| ToppCell | Sepsis-ICU-NoSEP-Myeloid-tDC|ICU-NoSEP / Disease, condition lineage and cell class | 7.23e-06 | 199 | 158 | 7 | 90ddd686b8f39c6f6134b9b048396cebcf8d0448 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 7.47e-06 | 200 | 158 | 7 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 7.47e-06 | 200 | 158 | 7 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-05 | 144 | 158 | 6 | 75b16adfbe84f69376e6566d531ba7919d5c5192 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.15e-05 | 169 | 158 | 6 | 78eb70dd916724e476eabccf18fb7fcec4210308 | |
| ToppCell | facs-Marrow-B-cells-24m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-05 | 172 | 158 | 6 | a7fd4d61fb5017dce001d69d6b9a01e6cdf58828 | |
| ToppCell | (00)_Basal-(1)_24hpi|(00)_Basal / shred by cell type and Timepoint | 3.59e-05 | 173 | 158 | 6 | a8e62e7d8baf6af691acd5c50deedbadc119ceba | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.83e-05 | 175 | 158 | 6 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.83e-05 | 175 | 158 | 6 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.95e-05 | 176 | 158 | 6 | 8d9d0fb46c418b2067be58aec822e8c2b1561461 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.08e-05 | 177 | 158 | 6 | 0417460bdb012bc43d7254377fa53d79cdab3f34 | |
| ToppCell | (09)_Ionocytes-(3)_72hpi|(09)_Ionocytes / shred by cell type and Timepoint | 4.56e-05 | 110 | 158 | 5 | fce7d5a0617fc664b657f5bb9abb290e7cc234cb | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-05 | 181 | 158 | 6 | 3fe648db1cb8326066d8bde3ca1287c5c9af19bd | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 4.76e-05 | 182 | 158 | 6 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 4.91e-05 | 183 | 158 | 6 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.91e-05 | 183 | 158 | 6 | d2074b13b4831ec18c81273d9a1ff673c3f6a16d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.91e-05 | 183 | 158 | 6 | 5a541a7f6c3514be8a13e988185dfe388c874f8b | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.06e-05 | 184 | 158 | 6 | a809b0fa52df8a159f60f87eefcef61220af5e34 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 5.21e-05 | 185 | 158 | 6 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.21e-05 | 185 | 158 | 6 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.21e-05 | 185 | 158 | 6 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.21e-05 | 185 | 158 | 6 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.37e-05 | 186 | 158 | 6 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.37e-05 | 186 | 158 | 6 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.37e-05 | 186 | 158 | 6 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-05 | 187 | 158 | 6 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.53e-05 | 187 | 158 | 6 | a6a112689d1c9049f57935ad9d2f4955538427de | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.70e-05 | 188 | 158 | 6 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-05 | 189 | 158 | 6 | 16a4c92dd7a0d60f3691bd3130a091a9a54730f1 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-05 | 189 | 158 | 6 | 4dc32b463546bbe7250dddd281b92ad17ec22da1 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-05 | 189 | 158 | 6 | 0d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 6.04e-05 | 190 | 158 | 6 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 6.40e-05 | 192 | 158 | 6 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-05 | 193 | 158 | 6 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 6.59e-05 | 193 | 158 | 6 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-05 | 193 | 158 | 6 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-05 | 193 | 158 | 6 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 194 | 158 | 6 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Duct|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.98e-05 | 195 | 158 | 6 | fdbb4abc0c79a6aeace71bfa5a5c5576ca39d758 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.18e-05 | 196 | 158 | 6 | fd18a9ae8401121ae276adff1a85d5f938e2df91 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-mesenchymal_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 7.18e-05 | 121 | 158 | 5 | 176de42c088988fe1a7838f96add26ee8a30e543 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.38e-05 | 197 | 158 | 6 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.59e-05 | 198 | 158 | 6 | 5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.59e-05 | 198 | 158 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.59e-05 | 198 | 158 | 6 | ff6d9455ebfe965cc6f48197172c0ebd3bddde81 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.59e-05 | 198 | 158 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.59e-05 | 198 | 158 | 6 | 5375a2895cf995f0db4a61861093f01794707901 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.59e-05 | 198 | 158 | 6 | 567fcf882c8612356946240843525b786f3c8dbe | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.59e-05 | 198 | 158 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.59e-05 | 198 | 158 | 6 | 0cd930e374c2c48d1991b51c025f9801b22ecee7 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.59e-05 | 198 | 158 | 6 | 35edf6d5bedc2181fbdd56f43e458bc39f4eca16 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.59e-05 | 198 | 158 | 6 | e0df6d6ff2a9c41d813f84a2a5ee7cb5f6fc3e30 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Radial_glial-oRG|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.80e-05 | 199 | 158 | 6 | 151bda6821b52cfb4491474892ecb45781522837 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 7.80e-05 | 199 | 158 | 6 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 158 | 6 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Mesenchymal-Mesoderm|1m / Sample Type, Dataset, Time_group, and Cell type. | 8.02e-05 | 200 | 158 | 6 | c0ad32e9dd7f481c2665587fd8bd9fffc2e725f9 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Mesoderm|5w / Sample Type, Dataset, Time_group, and Cell type. | 8.02e-05 | 200 | 158 | 6 | 0927061536a664b4f7feb9e5b0a8c11ca0d5955c | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Calb1_(Superficial_layer_pyramidal_cells--Layer_2/3)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.69e-05 | 126 | 158 | 5 | 7dcc79bf35482e8e5e5a1de7279ba080edb70522 | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.02e-05 | 127 | 158 | 5 | 556aaf88719c83f307fa50dfac151136ed05c8ad | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 140 | 158 | 5 | e442c46979d725ec82f525a001c46d971fcade4d | |
| Drug | Zonisamide | 8.20e-08 | 17 | 156 | 5 | DB00909 | |
| Drug | PKI166 | 9.09e-07 | 48 | 156 | 6 | CID006918403 | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A | POLM IQSEC2 HUWE1 SCEL PHLDB1 P2RY4 SRRM2 INPP5J MVB12B FBXW7 | 9.11e-07 | 193 | 156 | 10 | 4322_UP |
| Drug | prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A | ANK3 POLM ANKRD26 MLLT10 TMEM80 PDE8B MAP3K9 CACNA1H LTBP2 DAGLA | 1.00e-06 | 195 | 156 | 10 | 6552_DN |
| Drug | mibefradil | 5.07e-06 | 64 | 156 | 6 | CID000060662 | |
| Drug | PQ-2 | 6.22e-06 | 6 | 156 | 3 | CID005320689 | |
| Drug | SC-791 | 6.22e-06 | 6 | 156 | 3 | CID010291510 | |
| Drug | Glycopyrrolate [596-51-0]; Down 200; 10uM; PC3; HT_HG-U133A | 9.03e-06 | 197 | 156 | 9 | 7386_DN | |
| Drug | hydantoin-5-propionic acid | 1.16e-05 | 21 | 156 | 4 | CID000000782 | |
| Drug | lamotrigine | 1.55e-05 | 116 | 156 | 7 | CID000003878 | |
| Drug | AZFd | 1.70e-05 | 23 | 156 | 4 | CID000196489 | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 1.12e-17 | 46 | 157 | 12 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 ITPR1 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 4.94e-17 | 69 | 157 | 13 | DOID:1682 (implicated_via_orthology) |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 9.87e-10 | 10 | 157 | 5 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 9.87e-10 | 10 | 157 | 5 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 3.07e-09 | 12 | 157 | 5 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 1.07e-05 | 93 | 157 | 6 | C1535926 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.21e-05 | 9 | 157 | 3 | C3502809 | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 2.81e-05 | 2 | 157 | 2 | C4551549 | |
| Disease | spinocerebellar ataxia type 2 (implicated_via_orthology) | 2.81e-05 | 2 | 157 | 2 | DOID:0050955 (implicated_via_orthology) | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 3.14e-05 | 12 | 157 | 3 | DOID:1441 (implicated_via_orthology) | |
| Disease | Infantile Severe Myoclonic Epilepsy | 4.06e-05 | 13 | 157 | 3 | C0751122 | |
| Disease | B Virus Infection | 8.41e-05 | 3 | 157 | 2 | C0037140 | |
| Disease | Benign familial infantile epilepsy | 8.41e-05 | 3 | 157 | 2 | cv:C5575231 | |
| Disease | Postherpetic neuralgia | 8.41e-05 | 3 | 157 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 8.41e-05 | 3 | 157 | 2 | C0019372 | |
| Disease | Neuropathy, Hereditary Sensory And Autonomic, Type IIA | 1.68e-04 | 4 | 157 | 2 | C2752089 | |
| Disease | Pachyonychia congenita syndrome | 1.68e-04 | 4 | 157 | 2 | cv:C0265334 | |
| Disease | Hereditary sensory and autonomic neuropathy type 2 | 1.68e-04 | 4 | 157 | 2 | cv:C5574675 | |
| Disease | Neuropathy, hereditary sensory and autonomic, type 2A | 1.68e-04 | 4 | 157 | 2 | cv:C2752089 | |
| Disease | Pachyonychia Congenita, Jadassohn Lewandowsky Type | 1.68e-04 | 4 | 157 | 2 | C1706595 | |
| Disease | pachyonychia congenita (is_implicated_in) | 1.68e-04 | 4 | 157 | 2 | DOID:0050449 (is_implicated_in) | |
| Disease | NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA | 1.68e-04 | 4 | 157 | 2 | 201300 | |
| Disease | Pachyonychia Congenita, Type 2 (disorder) | 1.68e-04 | 4 | 157 | 2 | C1721007 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.69e-04 | 152 | 157 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 2.11e-04 | 22 | 157 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | Pachyonychia Congenita | 2.78e-04 | 5 | 157 | 2 | C0265334 | |
| Disease | Epilepsy | 2.99e-04 | 109 | 157 | 5 | C0014544 | |
| Disease | Epilepsy, Generalized | 4.16e-04 | 6 | 157 | 2 | C0014548 | |
| Disease | Familial benign neonatal epilepsy | 4.16e-04 | 6 | 157 | 2 | C0220669 | |
| Disease | Pigmented Basal Cell Carcinoma | 4.39e-04 | 28 | 157 | 3 | C1368275 | |
| Disease | Carcinoma, Basal Cell | 4.88e-04 | 29 | 157 | 3 | C4721806 | |
| Disease | Seizure, Febrile, Simple | 5.80e-04 | 7 | 157 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 5.80e-04 | 7 | 157 | 2 | C0751057 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 5.95e-04 | 31 | 157 | 3 | C1335167 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 7.71e-04 | 8 | 157 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 7.71e-04 | 8 | 157 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 7.71e-04 | 8 | 157 | 2 | C0338479 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 7.71e-04 | 8 | 157 | 2 | C0751120 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 7.71e-04 | 8 | 157 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | Myoclonic Encephalopathy | 7.71e-04 | 8 | 157 | 2 | C0438414 | |
| Disease | Arhinencephaly | 7.71e-04 | 8 | 157 | 2 | C0078982 | |
| Disease | Myoclonic Absence Epilepsy | 7.71e-04 | 8 | 157 | 2 | C0393703 | |
| Disease | Epilepsy, Cryptogenic | 9.77e-04 | 82 | 157 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 9.77e-04 | 82 | 157 | 4 | C0751111 | |
| Disease | Aura | 9.77e-04 | 82 | 157 | 4 | C0236018 | |
| Disease | Febrile Convulsions | 9.88e-04 | 9 | 157 | 2 | C0009952 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 9.88e-04 | 9 | 157 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | Myoclonic Epilepsy | 9.88e-04 | 9 | 157 | 2 | C0014550 | |
| Disease | Holoprosencephaly sequence | 1.23e-03 | 10 | 157 | 2 | cv:C0079541 | |
| Disease | Epilepsy, Myoclonic, Infantile | 1.23e-03 | 10 | 157 | 2 | C0917800 | |
| Disease | Myoclonic Astatic Epilepsy | 1.50e-03 | 11 | 157 | 2 | C0393702 | |
| Disease | hip geometry | 1.67e-03 | 44 | 157 | 3 | EFO_0004685 | |
| Disease | Clear Cell Meningioma | 1.79e-03 | 12 | 157 | 2 | C0431121 | |
| Disease | Intraventricular Meningioma | 1.79e-03 | 12 | 157 | 2 | C1334271 | |
| Disease | Benign Meningioma | 1.79e-03 | 12 | 157 | 2 | C0281784 | |
| Disease | Intraorbital Meningioma | 1.79e-03 | 12 | 157 | 2 | C1334261 | |
| Disease | Olfactory Groove Meningioma | 1.79e-03 | 12 | 157 | 2 | C1335107 | |
| Disease | Angioblastic Meningioma | 1.79e-03 | 12 | 157 | 2 | C1527197 | |
| Disease | Meningiomas, Multiple | 1.79e-03 | 12 | 157 | 2 | C0205834 | |
| Disease | Xanthomatous Meningioma | 1.79e-03 | 12 | 157 | 2 | C0457190 | |
| Disease | Angiomatous Meningioma | 1.79e-03 | 12 | 157 | 2 | C0334608 | |
| Disease | Psammomatous Meningioma | 1.79e-03 | 12 | 157 | 2 | C0334607 | |
| Disease | Fibrous Meningioma | 1.79e-03 | 12 | 157 | 2 | C0334606 | |
| Disease | Meningothelial meningioma | 1.79e-03 | 12 | 157 | 2 | C0334605 | |
| Disease | Hemangioblastic Meningioma | 1.79e-03 | 12 | 157 | 2 | C0334609 | |
| Disease | Transitional Meningioma | 1.79e-03 | 12 | 157 | 2 | C0334611 | |
| Disease | Hemangiopericytic Meningioma | 1.79e-03 | 12 | 157 | 2 | C0334610 | |
| Disease | Spinal Meningioma | 1.79e-03 | 12 | 157 | 2 | C0347515 | |
| Disease | Intracranial Meningioma | 1.79e-03 | 12 | 157 | 2 | C0349604 | |
| Disease | Papillary Meningioma | 1.79e-03 | 12 | 157 | 2 | C3163622 | |
| Disease | Malignant Meningioma | 1.79e-03 | 12 | 157 | 2 | C0259785 | |
| Disease | Sphenoid Wing Meningioma | 1.79e-03 | 12 | 157 | 2 | C1565951 | |
| Disease | Posterior Fossa Meningioma | 1.79e-03 | 12 | 157 | 2 | C1565950 | |
| Disease | Parasagittal Meningioma | 1.79e-03 | 12 | 157 | 2 | C0751304 | |
| Disease | Cerebral Convexity Meningioma | 1.79e-03 | 12 | 157 | 2 | C0751303 | |
| Disease | Microcystic meningioma | 1.79e-03 | 12 | 157 | 2 | C1384408 | |
| Disease | Secretory meningioma | 1.79e-03 | 12 | 157 | 2 | C1384406 | |
| Disease | epilepsy (implicated_via_orthology) | 1.84e-03 | 163 | 157 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 2.11e-03 | 13 | 157 | 2 | C0270914 | |
| Disease | cannabis dependence measurement | 2.14e-03 | 48 | 157 | 3 | EFO_0008457 | |
| Disease | amyotrophic lateral sclerosis, age at onset | 2.82e-03 | 15 | 157 | 2 | EFO_0004847, MONDO_0004976 | |
| Disease | MMR-related febrile seizures | 2.82e-03 | 15 | 157 | 2 | EFO_0006519 | |
| Disease | Alobar Holoprosencephaly | 2.82e-03 | 15 | 157 | 2 | C0431363 | |
| Disease | unipolar depression, cognitive function measurement | 2.82e-03 | 15 | 157 | 2 | EFO_0003761, EFO_0008354 | |
| Disease | Lobar Holoprosencephaly | 3.21e-03 | 16 | 157 | 2 | C0431362 | |
| Disease | Semilobar Holoprosencephaly | 3.21e-03 | 16 | 157 | 2 | C0751617 | |
| Disease | Dermatitis | 3.21e-03 | 16 | 157 | 2 | C0011603 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 3.21e-03 | 16 | 157 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 3.21e-03 | 16 | 157 | 2 | C0393706 | |
| Disease | Holoprosencephaly | 3.63e-03 | 17 | 157 | 2 | C0079541 | |
| Disease | serum gamma-glutamyl transferase measurement | ARHGEF19 MYO9A SEPTIN9 ITPR1 PKD1 DDRGK1 FAM53B YY1AP1 ULK1 ARHGEF2 SRSF9 DNMT3B | 3.67e-03 | 914 | 157 | 12 | EFO_0004532 |
| Disease | sphingomyelin measurement | 3.83e-03 | 278 | 157 | 6 | EFO_0010118 | |
| Disease | Malignant neoplasm of skin | 3.86e-03 | 59 | 157 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 3.86e-03 | 59 | 157 | 3 | C0037286 | |
| Disease | serum urea measurement | 3.97e-03 | 195 | 157 | 5 | EFO_0009795 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 4.07e-03 | 18 | 157 | 2 | HP_0002373 | |
| Disease | Malignant neoplasm of endometrium | 4.07e-03 | 18 | 157 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 4.07e-03 | 18 | 157 | 2 | C0346191 | |
| Disease | facial asymmetry measurement | 4.53e-03 | 19 | 157 | 2 | EFO_0009751 | |
| Disease | Meningioma | 4.53e-03 | 19 | 157 | 2 | C0025286 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GNRREGRRPSYSSSL | 321 | Q8IVW6 | |
| GFISGRRSRSASPST | 211 | P55198 | |
| GRGDAPNRSRNRSSS | 396 | Q9Y6R9 | |
| SSSHGPGFSRLNRRD | 51 | Q9BZ76 | |
| LNSSPLSRRARSTLG | 471 | Q9P2B7 | |
| RRSGNPSSLSDIGNR | 136 | P54284 | |
| PATRSLRRRATASAG | 141 | Q9UBC3 | |
| PGGRLSRASSRSVEF | 341 | P18825 | |
| PSDSFRQSLLGSRRG | 126 | Q92974 | |
| RSGSCSRTPRDVSGL | 566 | Q9BZE4 | |
| VAPRLYSTRSSSGGR | 721 | A8MVX0 | |
| PLRSTGATRSNRARS | 396 | Q9Y2X7 | |
| RGRSRPRGGTSQSDI | 366 | Q58WW2 | |
| RTGPSTGGRQRSRHE | 1781 | P20930 | |
| LRSPGGGDRSRSRAA | 966 | Q9NQ90 | |
| SPLGSFARRQRSSAG | 11 | Q9UPS8 | |
| QRRRASFRGPRSSSS | 21 | Q13515 | |
| LTRSRGRAASAGQEP | 21 | Q96HY6 | |
| QRQGSGRESPSLASR | 331 | Q8WWM7 | |
| RRARVGSPSGDAASS | 6 | Q9NP87 | |
| RNRSPSGSLRSARGS | 101 | P0DJD3 | |
| RNRSPSGSLRSARGS | 101 | A6NDE4 | |
| RNRSPSGSLRSARGS | 101 | P0DJD4 | |
| RNRSPSGSLRSARGS | 101 | P0C7P1 | |
| RNRSPSGSLRSARGS | 101 | A6NEQ0 | |
| RNRSPSGSLRSARGS | 101 | Q15415 | |
| GDRPTVSRFGAISRT | 871 | Q5TC82 | |
| STAPGAREGRSARRA | 51 | Q8WWW0 | |
| AASRLRGGTSSRRLS | 721 | O75665 | |
| RLADSRTNPAGRFST | 606 | Q02297 | |
| SSPRFAGSQRARTRT | 101 | Q14207 | |
| SPSSSFRAQRSARGS | 336 | Q8IW93 | |
| RASRASVSPGRTIRS | 16 | Q7RTS5 | |
| PRATTRQDSSLGGRA | 686 | Q8WXD9 | |
| GSSVNRRTRSGASPL | 161 | Q6ZVH7 | |
| RGFSANSARLPGVSR | 16 | P48668 | |
| PTSRATRGRTNRSSV | 1551 | Q14676 | |
| SPRGEARTRLGSASE | 506 | Q86Y46 | |
| VRPSGRRESLTSFGN | 1756 | Q14643 | |
| RGFSANSARLPGVSR | 16 | P02538 | |
| PRNHRVSAGRGSISS | 631 | Q99700 | |
| ERGQLSRGASRSSSP | 201 | Q5JU85 | |
| PGTGLRSRSTQQRSA | 341 | Q86X51 | |
| PVSATSGTFRLRRGS | 256 | Q6NT76 | |
| GSRELSLRPSRSGAQ | 36 | Q9Y6B2 | |
| LARRSSGLSRSRSQP | 256 | Q14153 | |
| RGFSANSARLPGVSR | 16 | P04259 | |
| GSAAPAATTSRGRRR | 81 | O95263 | |
| RSQPLFVTRTRGFGS | 131 | Q96MZ4 | |
| GRSGTISVNSRRTPF | 551 | Q9Y4C0 | |
| PSSGGSSRRFARLAA | 111 | Q96G03 | |
| TGSRTTSVRCRGIPR | 286 | Q86SG6 | |
| RSYRSSDGRTTPQLG | 946 | Q7Z3B3 | |
| GSDTSGLSRFSRSPR | 691 | Q9UQ05 | |
| SSRRSSEASPLGAGR | 831 | P10070 | |
| LSCGARRRAARGTSP | 31 | Q8N159 | |
| SPQGRLLGNSSRARA | 331 | Q9BTN0 | |
| PATGLGSFLRRTARS | 1311 | Q07864 | |
| RRNGLSRSSGAQPAS | 551 | O15297 | |
| RGDFSPLFTVRTRGS | 401 | Q8N1E6 | |
| RSPAFTSRLSGNRGV | 3126 | Q7Z6Z7 | |
| SSGSGTLPRARGRAS | 1201 | Q27J81 | |
| TLPATFRGRNSTRTD | 226 | Q9H7P6 | |
| RLAPRSQYTTGRGSS | 396 | P33993 | |
| LPGSAQSSSRLRSLR | 231 | P51582 | |
| QSRGGRGRPTLASRF | 196 | Q96JP2 | |
| SSPRLGRRGSRLSGA | 41 | P15863 | |
| PRRISVSRRTFGQSG | 316 | Q9Y2L6 | |
| APGGKSRRRRTAFTS | 256 | Q14549 | |
| SRQAGGLSRFPGARS | 216 | Q9BU40 | |
| RSTGGQAGSRRRPSA | 46 | Q86X59 | |
| KRRRTGGSLRGNPSS | 11 | Q969H0 | |
| APSATRTRRSASQAG | 36 | Q7Z7K6 | |
| AGSEKRSSRRTGPQS | 4071 | Q12955 | |
| RGTRPFVISRSTFAG | 591 | P10253 | |
| ERSPNLRRSSAAGEG | 241 | Q14767 | |
| GRDSQGKPSRSLTRT | 286 | Q502W7 | |
| RSSGFRSIRGSPSLH | 796 | Q9Y4D2 | |
| RGRVLFRPSDTANSS | 96 | Q8N4V1 | |
| DTLGRSGSDRLPSRF | 821 | Q6ZRV2 | |
| PSAAEGGSTTLRRRT | 2206 | O95180 | |
| SQRSGGRLSRFPRFV | 156 | P20160 | |
| ARRLRSSSRGQSTVG | 476 | Q5VV67 | |
| RGRRISGRQSAPSSS | 736 | Q96AC6 | |
| GLFQRSSRPRRSTSP | 796 | P80192 | |
| NRLRRGGPISFSSSR | 1926 | P35580 | |
| GGPISFSSSRSGRRQ | 1931 | P35580 | |
| SSSHGPGFSRLNRRD | 51 | Q96NU0 | |
| SRSIRNLFGSGSLRA | 1301 | Q12756 | |
| LQGRRSSRAPAGSSR | 4246 | P98161 | |
| RASRGVDLATGPSRT | 4276 | P98161 | |
| RQRRRSSTATPGVTS | 731 | O15211 | |
| SRRSRSGSSPGLRDG | 1436 | Q9UQ35 | |
| RSGSRGRDSPYQSRG | 196 | Q13242 | |
| PGAAVGASRSRRSLS | 81 | Q9BVQ7 | |
| APRRGRGSSTVLSSV | 76 | Q96HE8 | |
| TGPGGASRFRERSLS | 486 | Q5HYW2 | |
| DTSPSCRLRAFSRGG | 16 | Q86WR7 | |
| SVTRSSRRFLPARGS | 626 | Q8IVG5 | |
| GTFRRAQRRSFTPAS | 231 | Q96CC6 | |
| LPRGTSSFRRFTRES | 6 | Q14524 | |
| PLSIRGSLFSARRSS | 536 | Q15858 | |
| TSSGRLRRLGDSSGP | 11 | Q9UHD8 | |
| GRRTRGGARAALTSP | 46 | Q8TBK2 | |
| APRDRSSSFAGGRRL | 1166 | Q8TF72 | |
| SASRRRLSSASSPGG | 611 | Q8IXF0 | |
| FSRSRLSLGAGGRAT | 401 | Q8N4L1 | |
| RFSSLLPGGNRRNST | 151 | O95149 | |
| APSVGRRGARSSRLG | 66 | Q9BRJ9 | |
| SGRQTRPERSLATGQ | 1761 | Q9ULL5 | |
| STSARQSRTPRRNFG | 161 | Q8WXF0 | |
| STSSDPGSRQAGRRR | 416 | P98171 | |
| GSLFSPRRNSRTSLF | 561 | P35498 | |
| GTSDGRRQGHRSPSR | 1331 | Q8IY92 | |
| RARRGEGIQAPSFSS | 256 | O75908 | |
| SRNLVGRGSSPRGSL | 671 | P55197 | |
| PRLASFRSLRGSRGT | 371 | Q15642 | |
| APGRNASARRRSSSS | 366 | Q8N2M8 | |
| SGLRHLRATPNTRGS | 6 | Q8WUR7 | |
| SRVAPDRSSNGSSRG | 921 | Q15735 | |
| LSSSAGSGKRRRRGN | 156 | Q15583 | |
| RSAARPNRRAAATTG | 496 | Q92618 | |
| RGSVSGPEASRQRFR | 41 | P17040 | |
| TRGTRTRRDNGPVTS | 241 | A6NGC4 | |
| RFSHRTRGGGSSPQR | 106 | Q8N7X1 | |
| SSRSHGRLSGSARPQ | 526 | O15027 | |
| AGASPRRGELRRGSS | 2001 | Q15772 | |
| SGRSTPLFGRLRRAT | 2481 | Q15772 | |
| SSRRRAADGSLDTQP | 156 | P15923 | |
| TAGSKRSSSSRNRGP | 166 | Q9NX95 | |
| RSSSSRNRGPHGRSN | 171 | Q9NX95 | |
| APTRAVSSSSRARGG | 21 | Q9P2C4 | |
| GELGSPLRRSISSSR | 216 | Q9BQI7 | |
| RLSTFGRRGSSRPSK | 86 | A0A1B0GVG6 | |
| YNASSSTGTRRREPG | 171 | O95171 | |
| RRGASSSPQRRQSPS | 701 | Q8IYB3 | |
| RGSRGPGRSRSRSQS | 1356 | Q96MS0 | |
| GSLRREGFQPRSTDA | 506 | Q9Y4K3 | |
| NTGTLASLRGRARRS | 501 | D6R9N7 | |
| SIRGSLFSPRRNSRA | 561 | Q99250 | |
| ERTRRGRGAPAASSA | 776 | Q5VUG0 | |
| TSRLPGRSTSLVEGR | 51 | P26651 | |
| LRQSISFSGLPSGRR | 181 | P26651 | |
| NTGTLASLRGRARRS | 501 | A8MUK1 | |
| FSSRSLRSISERAPG | 86 | Q8N554 | |
| NTGTLASLRGRARRS | 501 | D6R901 | |
| NTGTLASLRGRARRS | 501 | C9JLJ4 | |
| SQGSRSSRIFPSLRR | 621 | Q9UQD0 | |
| APSAARSASARTGRS | 186 | Q9GZW5 | |
| NTGTLASLRGRARRS | 501 | D6RCP7 | |
| GSLLASGRAPRRASS | 16 | Q9UJZ1 | |
| EAGSSARSVPSIRRG | 81 | Q9NSI2 | |
| SLTLGARGRRTRSPS | 506 | Q86UU1 | |
| RRPSRGLAGASGRSS | 651 | Q86UU1 | |
| RRLRGPSTAATRFST | 76 | Q96GW9 | |
| PRSAGGSARRSAAVT | 41 | Q99835 | |
| SPTLATASSAGRLRR | 36 | Q6PKC3 | |
| SRSAAATNPGSRLTR | 6 | Q9H869 | |
| NTGTLASLRGRARRS | 501 | C9JPN9 | |
| SLRAFQSTRRGPSFS | 701 | Q8N895 | |
| NTGTLASLRGRARRS | 501 | Q0WX57 | |
| STSPTLRRLRTRGCG | 46 | Q6ZR37 | |
| SSSRGNTSTLRRGPG | 276 | Q8TEC5 | |
| GSRGSDSRRPVSRGS | 81 | P22735 | |
| ALVRSPSSRRGLNGT | 896 | Q9Y4F4 | |
| TCRSGSLLPGFRSRS | 351 | Q9C0I4 | |
| STSRNRLQSTRGAGR | 576 | Q86XD8 | |
| NTGTLASLRGRARRS | 501 | D6RA61 | |
| NTGTLASLRGRARRS | 501 | C9J2P7 | |
| NTGTLASLRGRARRS | 501 | D6RBQ6 | |
| QRRLSKGSFPTSRRN | 1186 | Q96J92 | |
| AIRRSGSTSPLGFAR | 461 | O75385 | |
| ESRGRRLSPQTGTTR | 326 | Q8N7P7 | |
| NTGTLASLRGRARRS | 501 | D6RJB6 | |
| AKSPRASGSGLTRRS | 216 | Q8WUU4 | |
| NTGTLASLRGRARRS | 501 | C9JVI0 | |
| SFSSGSSRPLQRPRG | 61 | Q6UXQ8 | |
| NGRTGIRQSRLSSGT | 801 | B2RTY4 |